TRWD 10-K & 10-Q changes, risk factors and insider trading
Tradewinds Universal · OTC · Food And Kindred Products · CIK 1916558 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
We are a smaller reporting company as defined in Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Removed heading “For the twelve months ended December 31, 2024”
Removed heading “Operating Activities”
Removed heading “Investing Activities”
Removed heading “Financing Activities”
Removed heading “Use of Estimates”
Largest changes
“Management has prepared operational estimates and believes it will have sufficient funds to support our operations and meet our debt obligations for at least the next twelve months. However, we may require additional cash resources in the future due to changing business conditions, the implementation of our strategy to expand, or other investments or acquisitions we might pursue. If our financial resources are inadequate to meet our capital needs, we may look to sell additional equity or debt securities or obtain further credit facilities. …”see in full comparison
“Despite the increase in assets and equity, the Company had limited cash on hand at December 31, 2025 and an accumulated deficit of approximately $1,183,067. In addition the company has cash of $16,638, accounts receivable of $48,750, and prepaid expenses of $25,445.These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The Company will require additional capital to fund ongoing operations and future growth initiatives. …”see in full comparison
“The accompanying financial statements have been prepared on a going concern basis, under which we are expected to be able to realize our assets and satisfy our liabilities in the normal course of business.”see in full comparison
see in full comparisonManagement'sTheDiscussion and Analysis of Financial Condition and Results of Operations discusses the Company'sCompany’s financial statementswhich have beenare prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts ofassetsassets, liabilities, revenues, andliabilitiesexpenses. Significantatestimates include thedatevaluation and impairment oftheintangiblefinancialassets,statementsstock-based compensation, and thereported amountsrecognition ofrevenuesrevenue from licensing andexpensesdistributionduring the reporting period. Management bases its estimates and judgments on historical experiences and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources.agreements. Actual results may differ fromthese estimatesthoseunder different assumptions or conditions.estimates.
“For the period ended December 31, 2024, the Company had operating expenses of $219,323. We had $51,838 in professional fees, which increased related to our registration statement filings. We had an increase in marketing fees, which were $148,093, attributed to the startup marketing for our UP Protein bars and marketing for our affiliate commission program. We had a loss of $5,000 for impairment of intangible assets. We had $5,133 in consulting fees, a decrease due to our marketing program. …”see in full comparison
Full comparison: every changed paragraph (55)
The following discussion and analysis of our
financial financial
condition and results of operations should be read in conjunction with our financial statements and the related notes to those
statements statements
included elsewhere in this prospectus.Annual report on Form 10-K. In addition to historical financial information, the following discussion
and analysis contain
forward-looking statements involving risks, uncertainties, and assumptions. Our actual results and timing of selected
events may differ
materially from those anticipated in these forward-looking statements due to many factors, including, but not limited
to, those discussed
under the section titled “Risk Factors” and elsewhere in this prospectus. See the section titled “Special
Note Regarding
Forward-Looking Statements” elsewhere in this prospectus.
Tradewinds Universal, Inc. is a holding company focused on developing, acquiring, and commercializing businesses with long-term growth potential. Historically, the Company’s operations have centered on the development and marketing of functional food products, including high-protein nutrition bars under the Universal Proteins (“UP”) brand, as well as the development and licensing of a canine pain relief formula. During 2024 and 2025, the Company shifted its strategic focus away from physical product sales toward licensing, distribution rights, and technology-enabled assets, including the acquisition of intangible assets through non-cash transactions.
The Company has not yet achieved profitability and continues to incur operating losses as it invests in product development, licensing arrangements, professional services, and public company compliance. Management believes these activities are necessary to position the Company for future revenue growth, although there can be no assurance that such efforts will be successful.
We specialize in developing, manufacturing, and distributing
nutrient-rich foods, distinguishing ourselves by integrating insect-based proteins into our products. Our primary product line is marketed
under the brand Universal Proteins (UP) and currently focuses on protein bars. The company plans to broaden its secondary business focus
to include pet foods, particularly developing, manufacturing, and distributing dog treats aimed at alleviating pain.
In early 2022, we began formulating recipes using
insect protein powder derived from crickets. Our CEO, Andrew Read, in collaboration with a nutritionist, formulated two different recipes
for the preparation of the first protein bars. During this process we narrowed our primary protein source to cricket (Orthoptera) powder
from ENTOMO FARMS, a Canadian Company that has supplied protein powder from crickets for over 10 years.
Following the initial development of our first bars,
we conducted a taste test to finalize the ingredients. Subsequently, we initiated the process of partnering with a copacker/manufacturer.
In March 2022, we visited the YouBar facility in Los Angeles, California, and enlisted their expertise to consult on and develop our initial
two bars, also referred to as SKUs: Chocolate Almond and Peanut Butter and Fruit. YouBar has developed and manufactured protein bars since
2006 for companies whose bars are sold in well-known retail establishments such as Whole Foods, Trader Joe's, Costco, Target, Amazon,
and GNS, according to their website www.youbars.com.
The R&D collaboration with YouBar spanned almost
a year to develop the first two flavors (SKUs). This comprehensive process involved testing various ingredient combinations for optimal
taste, experimenting with baking or rolling techniques for the bars, and refining the product to facilitate mass production. YouBar sourced
material for additional bar ingredients, such as: fruits and flavors, all of which received subsequent approval by the Company.
Following
the approval process, we progressed to the packaging development and manufacturing phase, which lasted approximately nine months. Tradewinds
was selective in the type of products and service providers it used for each aspect of packaging. Manufacturing and packaging of the two
formulated SKUs were completed and shipped on December 4, 2023, at which time we received the first order, which included 10,848 peanut
butter fruit bars and 10,764 chocolate almond bars. We have initiated online marketing and sales of the UP protein bars; however, our
main focus has been directed toward larger retail outlets and distributors such as Trader Joe’s, Costco, and Coremark. We anticipate
that it may take an uncertain amount of time to secure sales orders from larger retailers, if it happens at all. In April of 2024 we entered
into a purchase agreement with a smaller distributor for 1,040 cases of UP bars containing 12,480 bars for $24,960. At December 31, 2024,
all bars in inventory had been sold. Raw materials used in the protein bars are generic to energy protein bars sourced by YouBar. The
availability of ingredients is subject to standard supply and demand for energy bars. Protein Cricket Powder protein is purchased from
Entomo Farms, a
Company based out of Canada that has supplied protein powder from crickets for over 10 years. All ingredients required for the manufacturing
of the bars are currently abundant.
Our UP Protein Bars are currently backordered only
on our website, UPProteins.com. We have initiated a marketing program targeting retail outlets through social media platforms, as detailed
in our Business Description on page 12. We expect to finalize one more new SKU for a bar by the end of 2025. The Company
plans to expand its focus to include pet foods and has acquired a formula for developing, manufacturing, and distributing dog treats for
pain relief. Additionally, we aim to continue marketing Distribution Rights across various territories. We also plan to promote the licensing
rights for our pain relief formula for dogs as well as expand our affiliate marketing program. However, there is no guarantee that licensing
rights, products and affiliate commission income will be sufficient to support our operational plan. We anticipate raising capital through
revenues from licensing rights sales or through some form of debt or equity financing. Currently, we have no arrangements for any funding
sources.
We expect our operating expenses to significantly
increase as we continue to develop additional product lines and establish a market for our current product line. We also expect to incur
additional operating expenses as we begin operating as a public company. Our net losses may fluctuate significantly from quarter to quarter
and year to year, depending on the timing and scope of our marketing and our expenditures on other research and development activities.
Following the sale of our entire inventory of both
protein bar SKUs, we are currently assessing market reception and evaluating potential business models as well as evaluating new copackers
in the effort of obtaining more competitive pricing, and we are in the process of creating a third SKU to further expand our protein bar
offerings. These include white labeling our proprietary formulas and licensing rights for various territories. As of now, we have not
resumed the manufacturing or sale of our protein bars.
Beyond human nutrition, the Company has developed a proprietary
formula for dog pain relief treats. Last year, we successfully sold the exclusive licensing rights for this formula in Mexico, and we
are currently exploring white labeling and expanded licensing opportunities in additional markets.
Through these initiatives, we remain committed to delivering sustainable
and health-conscious solutions for both human and pet nutrition while strategically expanding our market presence.
As part of our growth strategy, we introduced an affiliate commission
program last year, which we plan to expand to enhance our market reach and sales performance.
Furthermore, as part of our long-term strategic direction,
we are actively exploring opportunities in the green business sector, which includes industries
and enterprises that prioritize environmental sustainability and eco-friendly practices while generating economic value. These are businesses
that aim to reduce environmental impact, conserve natural resources, and promote sustainable development. However, at this time, no definitive
plans have been established.
Comparison of yearsthe endedYears Ended December 31,
2025 2024,
and 20232024
For the year ended December 31, 2025, the Company generated total revenues of approximately $133,222. Revenue during 2025 was primarily derived from the sale of distribution and licensing rights. By comparison, for the year ended December 31, 2024, the Company generated revenues of approximately $171,596, which consisted primarily of affiliate marketing commissions, licensing activity, and sales of the Company’s UP protein bars. The decrease in revenue of $38,374 year-over-year was attributable to the discontinuation of physical product sales and a reduction in affiliate marketing activity as the Company transitioned its business model toward licensing and distribution arrangements.
For the period ended December 31, 2024, the Company
had total sales of $171,596. The increase in revenues was directly related to commissions from affiliate marketing, licensing rights to
our dog formula, and sales of the Company's UP protein bars.
For the period ended December 31, 2023, the Company
had total sales of $145,085. Revenues were directly related to the sales of commissions from affiliate marketing. The Company was in the
process of finalizing formulations for its protein bars and had not yet begun sales.
For the year ended December 31, 2025, the Company recorded no cost of goods sold, as revenues were derived from licensing and distribution rights that did not carry direct production or fulfillment costs. For the year ended December 31, 2024, cost of goods sold totaled approximately $21,645, reflecting manufacturing and fulfillment costs associated with sales of the Company’s UP protein bars.
For the period ended December 31, 2024, the Company
had cost of sales of $21,645. The increase was directly related to the sales of the Company's UP protein bars.
For the period ended December 31, 2023, the Company
had cost of sales of $13,023 as its UP- Protein bars were still being designed and formulated.
As a result of the absence of cost of goods sold in 2025, gross profit for the year ended December 31, 2025 was equal to total revenues of approximately $133,222, representing a gross margin of 100%. For the year ended December 31, 2024, gross profit totaled approximately $149,951, reflecting a gross margin of approximately 87%. The decline in gross profit was primarily driven by lower overall revenues, partially offset by improved margins due to the shift away from physical products.
For the period ended December 31, 2024, the Company
had a gross profit of $149,951 The increase from the same period in the previous year was directly related to the sales of the Company's
UP protein bars, licensing rights to our dog formula, and the increase of sales of commissions from affiliate marketing.
For the period ended December 31, 2023, the Company
had a gross profit of $132,062. The gross profit was less than the same period of 2024 as its UP Protein bars were still being designed
and formulated, and its sales of commissions from affiliate marketing program was just beginning.
Total operating expenses for the year ended December 31, 2025 were approximately $1,026,099, compared to approximately $219,323 for the year ended December 31, 2024. The increase in operating expenses was driven primarily by the sharp rise in consulting expense to $835,660 in 2025 from $5,133 in 2024, along with amortization of $14,800 and higher general and administrative costs, partially offset by lower marketing expense. The increase in operating expenses was primarily attributable to higher consulting and professional fees incurred in connection with business development activities, strategic advisory services, and the Company’s transition toward licensing and distribution-based operations. These increases were partially offset by lower marketing expenses following the discontinuation of UP protein bar sales.
For the twelve months ended December 31,
2024
For
the period ended December 31, 2024, the Company had operating expenses of $219,323. We had $51,838 in professional fees, which increased
related to our registration statement filings. We had an increase in marketing fees, which were $148,093, attributed to the startup marketing
for our UP Protein bars and marketing for our affiliate commission program. We had a loss of $5,000 for impairment of intangible assets.
We had $5,133
in consulting fees, a decrease due to our marketing program. We had $4,459 in general and administrative costs related to the expansion
of our business and
we had $4,800 in amortization.
For the period ended December 31, 2023, the Company
had operating expenses of $362,683. We had $18,442 in professional fees related to filing our registration statement. We had consulting
fees of $316,173 attributed to the shares issued to our CEO for services rendered as well as other consulting related expenses, marketing
fees of $23,562 attributed to the startup marketing for our UP Protein bars. We had $4,506 in general and administrative costs.
For the year ended December 31, 2025, the Company recorded a net loss of approximately $892,877, compared to a net loss of approximately $115,743 for the year ended December 31, 2024. The increase in net loss was primarily driven by the increase in consulting expense, including non-cash stock-based compensation/stock issued for services, plus higher amortization and general and administrative costs, partially offset by the absence of cost of goods sold in 2025.
For the period ended December 31, 2024, the Company had a net loss
of $115,743. Although our gross profit had increased to $149,951, we had operating expenses of $219,323. Our gross profit increased while
our total expenses decreased which were directly related to the sales of the Company's UP protein bars and the increase in sales of commissions
from affiliate marketing.
For the period ended December 31, 2023, the Company
had a net loss of $182,191. Although our gross profit increased to $132,062, we had operating expenses of $362,683. Our gross profit and
expenses were directly related to the initial startup of the Company's UP protein bars and the sales of commissions from affiliate marketing
as well as to the shares issued to our CEO for services rendered.
As of December 31, 2025, the Company had total assets of approximately $307,333, compared to total assets of approximately $31,510 as of December 31, 2024. The increase in total assets was primarily attributable to the acquisition of intangible assets and increases in accounts receivable and prepaid expenses associated with licensing and distribution activities.
The Company had no significant liabilities as of December 31, 2025. Stockholders’ equity totaled approximately $307,333 at December 31, 2025, compared to approximately $31,510 at December 31, 2024. The increase in stockholders’ equity was primarily the result of equity issuances for cash, services, and asset acquisitions during 2025.
Despite the increase in assets and equity, the Company had limited cash on hand at December 31, 2025 and an accumulated deficit of approximately $1,183,067. In addition the company has cash of $16,638, accounts receivable of $48,750, and prepaid expenses of $25,445.These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The Company will require additional capital to fund ongoing operations and future growth initiatives. Management intends to pursue additional equity financing, licensing revenue growth, and strategic partnerships; however, there can be no assurance that such financing or revenue will be available on acceptable terms, or at all.
Cash Flow Overview
The Company has historically funded operations primarily through equity issuances. During 2025, financing activities consisted mainly of proceeds from the issuance of common stock for cash, services, and asset acquisitions. Net cash used in operating activities was $(577,572) for 2025, reflecting the net loss adjusted for non-cash stock-based compensation of $894,700, amortization of $14,800, and changes in working capital, including increases in prepaid expenses and accounts receivable. Net cash used in investing activities was $(200,000), primarily related to the acquisition of intangible assets. Net cash provided by financing activities was $74,000, primarily from the issuance of common stock for cash.
As of December 31, 2024, we had cash and cash equivalents
of $210. To date, we have financed our operations primarily through revenue generated from operations, private placements of our securities,
and advances from our founder.
Management has prepared operational estimates and
believes it will have sufficient funds to support our operations and meet our debt obligations for at least the next twelve months. However,
we may require additional cash resources in the future due to changing business conditions, the implementation of our strategy to expand,
or other investments or acquisitions we might pursue. If our financial resources are inadequate to meet our capital needs, we may look
to sell additional equity or debt securities or obtain further credit facilities. Selling additional equity could dilute our stockholders’
interests. Taking on debt would increase our debt service obligations and may require us to agree to operational and financial covenants
that limit our operations. Financing may not be available in amounts or on terms that are acceptable to us, if at all. Any failure to
secure additional funds on favorable terms or at all could restrict our ability to expand our operations and negatively impact our overall
business prospects. There is no assurance that the Company will be successful. Without sufficient financing, there is substantial doubt
about the Company’s ability to continue as a going concern.
The
accompanying financial statements have been prepared on a going concern basis, under which we are expected to be able to realize our assets
and satisfy our liabilities in the normal course of business.
Operating Activities
For
the period ended December 31, 2024, the Company had operating expenses of $219,323. We had $51,838 in professional fees, which increased
related to our registration statement filings. We had an increase in marketing fees, which were $148,093, attributed to the startup marketing
for our UP Protein bars and marketing for our affiliate commission program. We had a loss of $5,000 for impairment of intangible assets.
We had $5,133
in consulting fees, a decrease due to our marketing program. We had $4,459 in general and administrative costs related to the expansion
of our business.
Investing Activities
For December 31, 2024, we used $0 in investing activities
and for the year ended December 31, 2023 we used $1,500 in investing activities for an intangible asset for website development.
Financing Activities
Our
financing activities generally consist of the proceeds from the sale of our common stock. During December 31, 2024, we had $0 in financing
activity, and for the year ended December 31, 2023 we had $32,000 in financing activities from the issuance of stock to our CEO for cash
received for stock .
The Company believes it has insufficient cash resources
available to fund its primary operation. The Company has no, current, off-balance sheet arrangements and does not anticipate entering
into any off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition. The
Company has no agreements in place with its shareholders, officer and director or with any third parties to fund operations beyond the
end of the Company's 4th quarter. The Company has not negotiated nor has available to it any other third-party sources of liquidity.
Off BalanceOff-Balance Sheet ItemsArrangements
WeThe doCompany does not have any off-balance sheet
arrangements, arrangements,
financings,special purpose entities, or other relationships withthat unconsolidatedwould entitieshave a material effect on its financial condition or otherresults
of persons, also known as “special purpose entities”
(SPEs).operations.
SignificantCritical Accounting Policies and Estimates
Management'sThe Discussion and Analysis of Financial
Condition and Results of Operations discusses the Company'sCompany’s financial statements which have beenare prepared
in accordance with accounting
principles generally accepted in the United States of America. The preparation of these financial statements
requires management to make
estimates and assumptions that affect the reported amounts of assetsassets, liabilities, revenues, and liabilitiesexpenses.
Significant atestimates include the datevaluation and impairment of theintangible financialassets, statementsstock-based compensation, and the reported
amountsrecognition of revenuesrevenue
from licensing and expensesdistribution during the reporting period. Management bases its estimates and judgments on historical experiences and
on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments
about the carrying value of assets and liabilities that are not readily apparent from other sources.agreements. Actual results may differ from these
estimatesthose under different assumptions or conditions.estimates.
Outlook
Management expects operating expenses to remain elevated as the Company continues to develop licensing opportunities, pursue strategic acquisitions, and meet its obligations as a public company. While management believes that the Company’s strategic shift toward licensing and distribution may provide improved margins and scalability, the Company expects to continue incurring net losses in the near term. The Company’s ability to achieve profitability will depend on its ability to generate sustainable revenues, control operating costs, and secure additional financing as needed.
Use of Estimates
The preparation of financial statements in conformity
with generally accepted accounting principles in the United States requires us to make estimates and assumptions that affect reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported
amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates.
What changed in the latest 10-Q
Risk Factors
As a smaller reporting company, we are not required to provide the information required by this item.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Largest changes
“On January 29, 2026, the Company entered into a Common Stock Purchase Agreement and related Registration Rights Agreement with RH2 Equity Partners, L.P. under an equity line of credit that permits the Company, at its election and subject to the agreement's terms and limitations, to sell up to $10,000,000 of common stock. On June 21, 2026, the Company issued 5,920,000 shares to RH2 pursuant to the equity line of credit agreement and recorded aggregate consideration of $182,810. The issuance increased common stock by $5,920 and additional paid-in capital by $176,890. …”see in full comparison
Comparison of thesee in full comparisonQuartersThree and Six Months EndedMarch 31,June 30, 2026 andMarchJune31,30, 2025
For thesee in full comparisonquarterthree months endedMarchJune31,30, 2026, the Company recorded a net loss of$125,341,$2,866,860, compared to a net loss of$1,112$25,143 for thequarterthree months endedMarchJune31,30, 2025. For the six months ended June 30, 2026, the Company recorded a net loss of $2,992,201, compared to a net loss of $26,255 for the six months ended June 30, 2025. The increase in net loss was primarily driven by the increase in operating expenses,partiallyparticularlyoffsetconsultingbyexpense,theincludingincrease in revenue and gross profit.stock-based compensation. Basicand diluted net loss per share was $0.01 for the quarter ended March 31, 2026, compared to $0.00 for the quarter ended March 31, 2025. Weighted average shares outstanding used in the calculation of basicand diluted net loss per sharewerewas43,418,358$0.02 and $0.04 for thequarterthree-endedandMarch 31,six-month 2026 periods, respectively, comparedandto32,170,000$0.00 fortheeachquartercomparableended2025March 31, 2025.period.
“On August 19, 2025, we entered into a non-binding Letter of Intent with Scar Holdings LLC, also known as Peppermint Hippo(TM), regarding the potential formation of a division focused on the acquisition and development of nightlife and hospitality venues under the Peppermint Hippo brand. The first proposed acquisition contemplated by the LOI is Peppermint Hippo Toledo, located in Toledo, Ohio, and the LOI further contemplates that we may evaluate possible acquisitions of additional Peppermint Hippo-branded venues over time. …”see in full comparison
“Net cash provided by financing activities was $133,000 for the six months ended June 30, 2026, consisting of $68,000 of proceeds from the sale of common stock and $65,000 of proceeds from notes payable. The Company also issued 5,920,000 shares to RH2 Equity Partners, L.P. on June 21, 2026 pursuant to the equity line of credit agreement and recorded aggregate consideration of $182,810. …”see in full comparison
Total operating expenses for thesee in full comparisonquarterthree months endedMarchJune31,30, 2026 were$147,141,$2,891,860, compared to$14,084$45,143 for thequarterthree months endedMarchJune31,30, 2025, an increase of$133,057.$2,846,717.OperatingFor the six months ended June 30, 2026, total operating expenses were $3,039,001, compared to $59,227 for the six months ended June 30, 2025, an increasetheof $2,979,774. The 2026periodsix-month expenses includedmarketingconsulting expense of$64,178, advertising expense of $411,$2,858,498, professional fees of$23,796,$51,083,consultingmarketing expense of$ 43,700,$90,313, amortization expense of$10,000,$20,000, and general and administrative expense of$5,056. Operating expenses for the 2025 period consisted primarily of consulting expense of $12,650, amortization expense of $1,200, and general and administrative expense of $234.$19,107.
Full comparison: every changed paragraph (19)
On August 19, 2025, we entered into a non-binding Letter of Intent with Scar Holdings LLC, also known as Peppermint Hippo(TM), regarding the potential formation of a division focused on the acquisition and development of nightlife and hospitality venues under the Peppermint Hippo brand. The first proposed acquisition contemplated by the LOI is Peppermint Hippo Toledo, located in Toledo, Ohio, and the LOI further contemplates that we may evaluate possible acquisitions of additional Peppermint Hippo-branded venues over time. No definitive acquisition agreement has been entered into, and any acquisition would be subject to due diligence, definitive agreements, required consents, financing, and regulatory and licensing approvals. Accordingly, there can be no assurance that any proposed acquisition or nightlife and hospitality division will be completed or established.
In August 2025, we signed a Letter of Intent
with Peppermint Hippo(TM) to create a dedicated nightlife and hospitality division. The LOI includes the acquisition of Peppermint Hippo
Toledo as the initial property, followed by a phased rollout of several clubs nationwide, including 8 Peppermint Hippo locations and
other affiliated brands owned or operated by Peppermint Hippo. This move represents a major strategic expansion into a new industry sector.
Comparison of the Quarters
Three and Six Months Ended March 31,June
30, 2026 and MarchJune 31,30, 2025
For the three months ended June 30, 2026, the Company generated revenue of $25,000, compared to $20,000 for the three months ended June 30, 2025, an increase of $5,000, or 25%. For the six months ended June 30, 2026, revenue was $46,800, compared to $32,972 for the six months ended June 30, 2025, an increase of $13,828, or approximately 42%. Revenue for the three months ended June 30, 2026 consisted of management fee income. Revenue for the six months ended June 30, 2026 consisted of $25,000 of management fee income, $6,800 of distribution income, and $15,000 of product sales. The comparable 2025 periods included management fee and distribution income.
For the quarter ended March 31, 2026, the Company
generated revenue of $21,800, compared to revenue of $12,972 for the quarter ended March 31, 2025. Revenue increased by $8,828, or approximately
68%, primarily due to increased licensing, distribution, and related business activity during the 2026 period.
Gross profit was $25,000 for the quarterthree months ended
June 30, 2026 and $46,800 for the six months ended MarchJune 31,
202630, was $21,800,2026, compared to gross$20,000 profitand of $12,972$32,972 for the quarterthree and six months ended MarchJune
30, 31,2025, 2025.respectively. The Company did not report cost of goods
soldsales for eitherany period presented,presented; and thereforetherefore, gross profit equaled revenue in both periods.revenue.
Total operating expenses for the quarterthree months ended
MarchJune 31,30, 2026 were $147,141,$2,891,860, compared to $14,084$45,143 for the quarterthree months ended MarchJune 31,30, 2025, an increase of $133,057.$2,846,717. OperatingFor the six months
ended June 30, 2026, total operating expenses were $3,039,001, compared to $59,227 for the six months ended June 30, 2025, an increase
theof $2,979,774. The 2026 periodsix-month expenses included marketingconsulting expense of $64,178, advertising expense of $411,$2,858,498, professional fees of $23,796,$51,083, consultingmarketing expense
of $ 43,700,$90,313, amortization expense of $10,000,$20,000, and general and administrative expense of $5,056. Operating expenses for the
2025 period consisted primarily of consulting expense of $12,650, amortization expense of $1,200, and general and administrative expense
of $234.$19,107.
The increase in operating expenses was primarily attributable
attributableto tosubstantially higher marketingconsulting activity,costs, together with increased professional fees, consultingmarketing expenses,activity, amortization, and general and
administrative costs
incurred in connection with business development activities, strategic initiatives, capital-raising activities, and
the Company’s public-company obligations.
For the quarterthree months ended MarchJune 31,30, 2026, the Company
recorded a net loss of $125,341,$2,866,860, compared to a net loss of $1,112$25,143 for the quarterthree months ended MarchJune 31,30, 2025. For the six months ended
June 30, 2026, the Company recorded a net loss of $2,992,201, compared to a net loss of $26,255 for the six months ended June 30, 2025.
The increase in net loss was
primarily driven by the increase in operating expenses, partiallyparticularly offsetconsulting byexpense, theincluding increase in revenue and gross profit.stock-based
compensation. Basic and diluted
net loss per share was $0.01 for the quarter ended March 31, 2026, compared to $0.00 for the quarter ended March 31, 2025. Weighted average
shares outstanding used in the calculation of basic and diluted net loss per share werewas 43,418,358$0.02 and $0.04 for the quarterthree- endedand March 31,six-month 2026 periods, respectively, compared
andto 32,170,000$0.00 for theeach quartercomparable ended2025 March 31, 2025.period.
As of MarchJune 31,30, 2026, the Company had total assets
of $283,992,$276,331, compared to total assets of $307,333 as of December 31, 2025. Current assets at MarchJune 31,30, 2026 were $77,492,$79,831, consisting
of cash and cash equivalents
of $8,636, accounts receivable of $15,597,$70,750, and prepaid expenses of $12,945,$445. and accounts receivable of $48,950. OtherIntangible assets, net, were $206,500
$196,500 at MarchJune 30, 2026, compared
to $216,500 at December 31, 2026,2025. consistingThe primarilydecrease in intangible assets reflects $20,000 of theamortization AIexpense apprecorded intangible asset, net of amortization, of $180,000,during the Formula-Petssix intangiblemonths
assetended ofJune $25,000,30, and trademarks of $1,500.2026.
As of MarchJune 31,30, 2026, the Company had total liabilities
of $52,000,$92,000, consisting of accounts payable of $27,000 and a loan payable of $25,000$65,000, andcompared accounts payable of $27,000. The Company hadto no liabilities reported at December
31, 2025. Stockholders’ equity totaled $231,992$184,331 at MarchJune 31,30, 2026, compared to $307,333 at December 31, 2025. The decrease in stockholders’
equity during the quarter was primarily attributable to the net loss of $125,341,$2,992,201, partially offset by the issuanceissuances of common stock for
cash.stock.
At MarchJune 31,30, 2026, the Company had 43,690,580129,810,580 shares
shares of common stock issued and outstanding, compared to 42,690,580 shares issuedat andDecember outstanding31, 2025. Common stock totaled $129,811 at June 30,
2026, compared to $42,691 at December 31, 2025. Additional
paid-in capital was $1,496,709$4,412,599 at MarchJune 31,30, 2026, compared to $1,447,709 at
December 31, 2025. The Company also recorded a stock subscription receivable of $182,810 as contra-equity at June 30, 2026. The accumulated
deficit increased to $1,308,408
$4,175,269 at MarchJune 31,30, 2026 from $1,183,067 at December 31, 2025.
On January 29, 2026, the Company entered into a Common Stock Purchase Agreement and related Registration Rights Agreement with RH2 Equity Partners, L.P. under an equity line of credit that permits the Company, at its election and subject to the agreement's terms and limitations, to sell up to $10,000,000 of common stock. On June 21, 2026, the Company issued 5,920,000 shares to RH2 pursuant to the equity line of credit agreement and recorded aggregate consideration of $182,810. The issuance increased common stock by $5,920 and additional paid-in capital by $176,890. Because the consideration had not been received as of June 30, 2026, the Company recorded a $182,810 stock subscription receivable as a contra-equity account. Consequently, the issuance increased the number of shares issued and outstanding but did not provide cash liquidity as of June 30, 2026.
The Company continues to have limited cash resources.
At MarchJune 31,30, 2026, cash and cash equivalents were $15,597.$8,636. TheseThe conditionsrecurring losses, accumulated deficit of $4,175,269, and $141,002 of cash
used in operating activities during the six months ended June 30, 2026 raise substantial doubt about the Company’s ability
to continue
as a going concern. The Company will require additional capital to fund ongoing operations and future growth initiatives.
Management intends
to pursue additional equity financing, debt financing, licensing revenue growth, and strategic partnerships; however,
there can be no assurance
that such financing or revenue will be available on acceptable terms, or at all.
Net cash used in operating activities was $76,041$141,002
for the quartersix months ended MarchJune 31,30, 2026, compared to net cash provided by operating activities of $88$120 for the quartersix months ended MarchJune 31,30,
2025. 2025.
The cash used in operating activities during the 2026 periodamount was primarily attributable to the net loss of $125,341,$2,992,201 partially offset
by non-cash amortization of $10,000, a decrease in prepaid expenses of $12,500,and an increase in accounts payablereceivable of $27,000,$22,000, andpartially
offset by $20,000 of non-cash amortization, $2,801,200 of stock issued for services, a $200$25,000 decrease in prepaid expenses, a $27,000
increase in accounts receivable.payable, and a $1 rounding adjustment.
The
Company had no cash provided by or used in
investing activities for the quarterssix months ended MarchJune 31,30, 2026 and MarchJune 31,30, 2025.
Net cash provided by financing activities was $133,000 for the six months ended June 30, 2026, consisting of $68,000 of proceeds from the sale of common stock and $65,000 of proceeds from notes payable. The Company also issued 5,920,000 shares to RH2 Equity Partners, L.P. on June 21, 2026 pursuant to the equity line of credit agreement and recorded aggregate consideration of $182,810. Because payment had not been received as of June 30, 2026, the Company recorded the amount as a stock subscription receivable within contra-equity, and the transaction was excluded from cash provided by financing activities and disclosed as a supplemental non-cash financing activity. The Company had no cash provided by or used in financing activities for the six months ended June 30, 2025.
Net cash provided by financing activities was
$75,000 for the quarter ended March 31, 2026, consisting of $25,000 from a loan and $50,000 from the issuance of common stock. The Company
had no cash provided by or used in financing activities for the quarter ended March 31, 2025.
As
a result of the foregoing, cash and cash equivalents
decreased by $1,041$8,002 during the quartersix months ended MarchJune 31,30, 2026, from $16,638 at December
31, 2025 to $15,597$8,636 at MarchJune 31,30, 2026. For the
quarter six months ended MarchJune 31,30, 2025, cash and cash equivalents increased by $88,$120, from $210 at
December 31, 2024 to $298$330 at MarchJune 31,30, 2025.
TRWD insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding TRWD (13F)
None of the 59 investors we track reported a position in their latest 13F.